APA (7th ed.) Citation

CE, S., ML, H., DL, F., PE, K., TL, D., JS, N., . . . PD, C. (2022). BDNF rs6265 Genotype Influences Outcomes of Pharmacotherapy and Subthalamic Nucleus Deep Brain Stimulation in Early-Stage Parkinson's Disease. Neuromodulation : journal of the International Neuromodulation Society, 25(6), 846. https://doi.org/10.1111/ner.13504

Chicago Style (17th ed.) Citation

CE, Sortwell, et al. "BDNF Rs6265 Genotype Influences Outcomes of Pharmacotherapy and Subthalamic Nucleus Deep Brain Stimulation in Early-Stage Parkinson's Disease." Neuromodulation : Journal of the International Neuromodulation Society 25, no. 6 (2022): 846. https://doi.org/10.1111/ner.13504.

MLA (9th ed.) Citation

CE, Sortwell, et al. "BDNF Rs6265 Genotype Influences Outcomes of Pharmacotherapy and Subthalamic Nucleus Deep Brain Stimulation in Early-Stage Parkinson's Disease." Neuromodulation : Journal of the International Neuromodulation Society, vol. 25, no. 6, 2022, p. 846, https://doi.org/10.1111/ner.13504.